Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus

被引:4
|
作者
Gustafson, JE [1 ]
O'Brien, FG
Coombs, GW
Malkowski, MJ
Grubb, WB
Pfeltz, RF
Wilkinson, BJ
机构
[1] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA
[2] Curtin Univ Technol, Gram Posit Bacteria Typing & Res Unit, Perth, WA 6845, Australia
[3] Royal Perth Hosp, Perth, WA 6845, Australia
[4] Illinois State Univ, Dept Biol Sci, Microbiol Grp, Normal, IL 61790 USA
关键词
D O I
10.1099/jmm.0.05210-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability of phage-typing and Smal chromosomal RFLPs to conclude appropriate strain relatedness between a collection of 12 well-characterized in vitro-selected vancomycin-intermediate Staphylococcus aureus (VISA) strains and their seven vancomycin-susceptible parent strains is reported. Generally, no Smal RFLP alterations were observed in VISA strains when they were compared with their respective parent strains, and clonal relationships between isogenic strains were clearly evident. Unlike the Smal RFLP results, parent strains and VISA derivatives generally did not share similar phage-typing profiles. Depending on the phage set investigated, some VISA strains even became untypable by this method. Loss of phage infectivity is probably due to cell wall (phage receptor) alterations that are expressed by the VISA strains investigated. Collectively, these findings indicate that inappropriate relationships between VISA and vancomycin-susceptible parents might be drawn if only phage-typing and antibiotic susceptibility are utilized to determine epidemiological relationships.
引用
收藏
页码:711 / 714
页数:4
相关论文
共 50 条
  • [41] Comparative proteomic analysis of vancomycin-sensitive and vancomycin-intermediate resistant Staphylococcus aureus
    Jian Hu
    Xinjun Han
    Xiaoxue Ma
    Xutao Chen
    Zhenping Zhou
    Peilan Peng
    Zhao Yu
    Yongzhi Hou
    Peiru Han
    Long Pang
    Yali Yang
    Jia Xu
    Wenhui Wu
    European Journal of Clinical Microbiology & Infectious Diseases, 2024, 43 : 139 - 153
  • [42] Heterogeneous Vancomycin-Intermediate Staphylococcus aureus(HVISA) at a Tertiary Hospital in Malaysia
    Hamasalih, Bakhtiyar Mahmood
    Neoh, Hui-Min
    Ibrahim, Rosni
    Nor, Lailatul Akmar Mat
    Jamaluddin, Tengku Zetty Maztura Tengku
    SAINS MALAYSIANA, 2022, 51 (03): : 795 - 801
  • [43] Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
    Leonard, Steven N.
    Rolek, Kiri M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 644 - 647
  • [44] Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)
    Su, Michelle
    Davis, Michelle H.
    Peterson, Jessica
    Solis-Lemus, Claudia
    Satola, Sarah W.
    Read, Timothy D.
    PEERJ, 2021, 9
  • [45] Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus
    O'Neill, AJ
    Chopra, I
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) : 1484 - 1485
  • [46] The quest to identify heterogeneously resistant vancomycin-intermediate Staphylococcus aureus strains
    Tenover, Fred C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (04) : 303 - 306
  • [47] Emergence of vancomycin-intermediate Staphylococcus aureus and S-sciuri, Greece
    Tsakris, A
    Papadimitriou, E
    Douboyas, J
    Stylianopoulou, F
    Manolis, E
    EMERGING INFECTIOUS DISEASES, 2002, 8 (05) : 536 - 537
  • [48] Improved Antimicrobial Activity of Linezolid against Vancomycin-Intermediate Staphylococcus aureus
    Watanabe, Yukiko
    Neoh, Hui-min
    Cui, Longzhu
    Hiramatsu, Keiichi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 4207 - 4208
  • [49] Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus
    Cui, LZ
    Iwamoto, A
    Lian, JQ
    Neoh, HM
    Maruyama, T
    Horikawa, Y
    Hiramatsu, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 428 - 438
  • [50] Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
    Cui, LZ
    Tominaga, E
    Neoh, HM
    Hiramatsu, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 1079 - 1082